Completed
Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451
NCT01196676
- Conditions
- Behavior, Behavioral Symptoms, Bipolar Disorder, +4 more
- Locations
-
- Research Site Overland Park, Kansas, United States